3 Stocks to Watch in the Changing Landscape of ADHD Drugs

Johnson & Johnson's involvement in the ADHD market doesn't end with Concerta, however. Its antipsychotic drug Risperdal has also been prescribed to children with ADHD in the past. That practice, along with several other controversial uses, led to a $2.2 ...



from Meta Search Alerts http://ift.tt/1hUd3K8

via IFTTT